Open AccessNew treatment alternatives in ankylosing spondylitis and psoriatic arthritis
Author(s) -
Sebastián Ibáñez Vodnizza,
Oriela Martínez,
Francisca Valenzuela
Publication year - 2022
Publication title -
global rheumatology
Language(s) - English
Resource type - Journals
ISSN - 2709-5533
DOI - 10.46856/grp.10.et111
Subject(s) - psoriatic arthritis , medicine , ankylosing spondylitis , tofacitinib , psoriasis , personalization , dermatology , spondylitis , intensive care medicine , rheumatoid arthritis , computer science , world wide web
In psoriatic arthritis and spondyloarthritis, there is still room for new drugs, with different mechanisms of action, that allow better personalization of treatment. The objective of this review is to facilitate the clinician's decision to use tofacitinib, upadacitinib, or guselkumab, new treatment alternatives within the wide variety of drugs currently available